Skip to main content
SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. logo

SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603231 ISIN · CNE100006DV2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2025-04-24 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603231

About SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD.

https://www.solbar.com/

SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. is a specialized manufacturer of high-quality soy protein ingredients. The company produces a comprehensive range of products, including soy protein isolates, functional concentrates, textured soy proteins, and soy fibers. These ingredients are utilized extensively in the global food and beverage sectors, serving applications in meat processing, plant-based alternatives, nutritional supplements, and bakery products. The company emphasizes the use of non-GMO raw materials and advanced processing technologies to ensure high functionality and nutritional value. Its operations focus on delivering consistent quality and technical support to meet the evolving demands of the health-conscious consumer market and industrial food production.

Recent filings

Filing Released Lang Actions
独立董事2024年度述职报告（宿献荣）
Board/Management Information Classification · 95% confidence The document is a detailed annual performance report of an independent director of Ningbo Suobao Protein Technology Co., Ltd. It includes the director's background, attendance at meetings, participation in committees, communication with auditors, and evaluation of company governance and financial reporting for the year 2024. The content focuses on the director's duties, oversight, and opinions on company operations and governance rather than financial statements or audit results alone. It is a formal report on the director's annual duties and responsibilities, which aligns with the category of Board/Management Information (MANG), as it relates to management and board-level disclosures about governance and director activities. The document is not an audit report, annual report, or regulatory filing, but a specific director's annual report on their role and activities.
2025-04-24 Chinese
2025年第一季度主要经营数据公告
Earnings Release Classification · 90% confidence The document is titled as a "2025年第一季度主要经营数据公告" which translates to "2025 First Quarter Main Operating Data Announcement." It provides detailed sales data for the first quarter of 2025, including product categories, sales modes, and sales regions. The document is relatively short (1215 characters) and focuses on key operating data for a quarter, not a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). Instead, it is a brief announcement of main operating data for the quarter, which aligns with the characteristics of an Earnings Release (ER) that provides initial highlights of quarterly results. Therefore, the document should be classified as an Earnings Release (ER). Q1 2025
2025-04-24 Chinese
第三届监事会第三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a supervisory board meeting resolution announcement from Ningbo Suobao Protein Technology Co., Ltd. It details the approval of various reports and proposals including the 2024 annual report, 2024 financial statements, internal control evaluation report, profit distribution plan, and the 2025 first quarter report. The document itself is a meeting resolution announcement and does not contain the full financial reports or detailed financial data. It also references that the full reports are disclosed separately on the Shanghai Stock Exchange website. The document length is 2067 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal announcement of supervisory board resolutions and references other filings but does not contain the full reports themselves.
2025-04-24 Chinese
宁波索宝蛋白科技股份有限公司内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report' for the year 2024. It is issued by an accounting firm (利安达会计师事务所) and addresses the effectiveness of the company's internal control over financial reporting as of December 31, 2024. The content focuses on the audit of internal controls, the responsibilities of the company and auditors, and the audit opinion on internal control effectiveness. The document length is about 1304 characters, indicating it is a standalone audit report rather than a full annual report or other type. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-24 Chinese
2025年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2025 First Quarter Report" of 宁波索宝蛋白科技股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as revenue, net profit, earnings per share, asset and equity figures, and a consolidated balance sheet as of March 31, 2025. The report explicitly states it is unaudited and includes comprehensive financial statements and analysis for the quarter. This matches the definition of an Interim / Quarterly Report (IR), which must contain actual financial statements and substantive financial data for a period shorter than a full fiscal year. The document is not a brief announcement or a certification letter, but a full quarterly report with detailed financials and shareholder information. Q1 2025
2025-04-24 Chinese
宁波索宝蛋白科技股份有限公司募集资金年度存放与实际使用情况的鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "鉴证报告" (Assurance Report) on the "募集资金年度存放与实际使用情况" (Annual Deposit and Actual Use of Raised Funds) for the year 2024 by 宁波索宝蛋白科技股份有限公司. It includes detailed information about the company's fundraising (募集资金), the management and use of these funds, compliance with regulatory guidelines from the China Securities Regulatory Commission (CSRC) and Shanghai Stock Exchange, and an auditor's assurance opinion. The document is not a full annual report or earnings release but a specialized assurance report focused on the use and management of raised capital. It is a standalone audit-related report verifying compliance with fundraising regulations and usage, which fits the definition of an Audit Report / Information (AR). The document length is substantial (15,000 characters), and it contains detailed financial and compliance information, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-24 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.